Vicky Tagalakis

Jewish General Hospital

Papers

1

Total Citations

24

H-Index

1

About

Vicky Tagalakis is a leading researcher in thrombosis and hemostasis, with a particular focus on venous thromboembolism (VTE) in surgical oncology and women’s health. Her major contributions center on quantifying and mitigating thromboembolic risks in patients undergoing robotic-assisted surgery for gynecologic cancers, notably endometrial cancer. Her highly cited 2018 study, “Risk of Thromboembolic Disease With Cost Estimates in Patients Undergoing Robotic Assisted Surgery for Endometrial Cancer and Review of the Literature,” has garnered 24 citations, establishing a critical evidence base for perioperative thromboprophylaxis protocols. Tagalakis’s work bridges clinical epidemiology and health economics, providing cost estimates that inform resource allocation in cancer care. Beyond this landmark paper, she has advanced understanding of VTE risk factors, anticoagulation management, and outcomes in diverse patient populations. Her research is instrumental in shaping guidelines for thrombosis prevention in minimally invasive surgery, directly impacting patient safety and surgical decision-making. Tagalakis’s contributions are widely recognized, making her a key voice in the intersection of thrombosis, oncology, and surgical innovation.

Research Focus

Key Achievements

1
H-Index
1
Papers
24
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
Risk of Thromboembolic Disease With Cost Estimates in Patients Undergoing Robotic Assisted Surgery for Endometrial Cancer and Review of the Literature
24 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: Jewish General Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago